Pernix Therapeutics Holdings, Inc.
(NASDAQ : PTX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
ICPTIntercept Pharmaceuticals, Inc.
-0.30%66.8622.0%$202.70m
ZGNXZogenix, Inc.
1.97%38.8516.8%$132.01m
SHPGShire PLC Sponsored ADR
-3.34%146.970.4%$117.46m
VRXValeant Pharmaceuticals International, Inc.
-3.34%12.3814.2%$102.09m
PRGOPerrigo Co. Plc
-0.54%88.116.5%$92.91m
AERIAerie Pharmaceuticals, Inc.
-0.23%64.458.6%$65.64m
MNKMallinckrodt Plc
-0.19%32.3017.7%$57.12m
CTLTCatalent Inc
1.28%42.082.7%$56.96m
PTLAPortola Pharmaceuticals, Inc.
-0.22%50.397.9%$52.57m
JAZZJazz Pharmaceuticals Plc
-0.15%140.302.2%$51.17m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.00%110.817.6%$49.29m
UTHRUnited Therapeutics Corporation
-0.27%121.4614.4%$46.92m
ENDPEndo International Plc
-0.33%7.628.9%$39.00m
SUPNSupernus Pharmaceuticals, Inc.
0.20%41.136.4%$37.71m
HZNPHorizon Pharma plc
0.58%13.867.6%$36.41m

Company Profile

Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. The company's products include treatment of migraine pain and inflammation, insomnia, and depressive disorder. It distributes products under the following brands: Treximet, Silenor, Zohydro ER with BeadTek, and Khedezla. The company was founded on March 9, 2010 and is headquartered in The Woodlands, TX.